Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells - PubMed (original) (raw)

Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells

B Gardner et al. Br J Pharmacol. 1996 Jul.

Abstract

1. The activation of G-proteins by agonist-occupied D2 or D3 dopamine receptors in membranes from recombinant cells expressing the cloned receptors has been analysed by a [35S]-guanosine 5'-[gamma-thio] triphosphate ([35S]-GTP gamma S) binding assay. 2. The rate of [35S]-GTP gamma S binding was increased by dopamine in a dose-dependent manner in membranes from CHO cells stably expressing either the D2short or D2long dopamine receptor. 3. The dopamine-induced stimulation of [35S]-GTP gamma S binding could be inhibited by a range of antagonists. Affinities for antagonists derived from the inhibition of the dopamine stimulation of [35S]-GTP gamma S binding correlated very well with affinities derived from radioligand binding studies. 4. When the maximum [35S]-GTP gamma S binding responses stimulated by dopamine acting at different receptor subtypes were compared, there was a tendency for the stimulation via the D2short receptor to be greater than via the D2long receptor and for the stimulation via the D3 dopamine receptor to be less than for either D2 receptor. These differences in maximal response were also seen when the inhibitory effects of dopamine on adenylyl cyclase via the three receptor subtypes were compared. 5. The stimulation of [35S]-GTP gamma S binding by dopamine in membranes from recombinant cells therefore provides an excellent system for studying the molecular nature of agonism and the receptor/G-protein interactions for these receptors.

PubMed Disclaimer

Cited by

Constitutive phosphorylation by protein kinase C regulates D1 dopamine receptor signaling.
Rankin ML, Sibley DR. Rankin ML, et al. J Neurochem. 2010 Dec;115(6):1655-67. doi: 10.1111/j.1471-4159.2010.07074.x. Epub 2010 Nov 19. J Neurochem. 2010. PMID: 20969574 Free PMC article.
G protein-coupled receptor kinase-2 constitutively regulates D2 dopamine receptor expression and signaling independently of receptor phosphorylation.
Namkung Y, Dipace C, Urizar E, Javitch JA, Sibley DR. Namkung Y, et al. J Biol Chem. 2009 Dec 4;284(49):34103-15. doi: 10.1074/jbc.M109.055707. Epub 2009 Oct 8. J Biol Chem. 2009. PMID: 19815545 Free PMC article.
Investigating the ligand agonism and antagonism at the D2long receptor by dynamic mass redistribution.
Forster L, Pockes S. Forster L, et al. Sci Rep. 2022 Jun 10;12(1):9637. doi: 10.1038/s41598-022-14311-w. Sci Rep. 2022. PMID: 35688965 Free PMC article.
A single-point mutation (Ala280Val) in the third intracellular loop alters the signalling properties of the human histamine H₃ receptor stably expressed in CHO-K1 cells.
Flores-Clemente C, Osorio-Espinoza A, Escamilla-Sánchez J, Leurs R, Arias JM, Arias-Montaño JA. Flores-Clemente C, et al. Br J Pharmacol. 2013 Sep;170(1):127-35. doi: 10.1111/bph.12257. Br J Pharmacol. 2013. PMID: 23713487 Free PMC article.
Analysis of molecular determinants of affinity and relative efficacy of a series of R- and S-2-(dipropylamino)tetralins at the 5-HT1A serotonin receptor.
Alder JT, Hacksell U, Strange PG. Alder JT, et al. Br J Pharmacol. 2003 Mar;138(6):1129-39. doi: 10.1038/sj.bjp.0705085. Br J Pharmacol. 2003. PMID: 12684269 Free PMC article.

References

1. Anal Biochem. 1974 Apr;58(2):541-8 - PubMed
1. J Recept Signal Transduct Res. 1995 Jan-Mar;15(1-4):199-211 - PubMed
1. Proc R Soc Lond B Biol Sci. 1983 Dec 22;220(1219):141-62 - PubMed
1. Mol Pharmacol. 1984 Sep;26(2):214-27 - PubMed
1. Biochemistry. 1984 Nov 6;23(23):5467-71 - PubMed

Pharmacological analysis of dopamine stimulation of [35S]-GTP gamma S binding via human D2short and D2long dopamine receptors expressed in recombinant cells - PubMed (original) (raw)